Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Inactivation of parvovirus B19 during STIM-4 vapor heat treatment of three coagulation factor concentrates.

Transfusion - 1 Jun 2008

Berting Andreas, Modrof Jens, Unger Ulrike, Gessner Matthias, Klotz Andreas, Poelsler Gerhard, Kreil Thomas R

Abstract excerpt

BACKGROUND: To enhance the viral safety margins, nanofiltration has been widely integrated into the manufacturing process of plasma-derived medicinal products. Removal of smaller agents such as parvovirus B19 (B19V) by filtration, however, is typically less efficient. Because recent investigations have demonstrated that B19V may be more heat sensitive than animal parvoviruses, the potential B19V inactivation by a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Donors
Share to Enzyme Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Factor VIII

Share to Filtration

Share to Hot Temperature

Share to Kinetics

Share to Nanostructures

Share to Parvovirus B19, Human

Source

Identifiers

PMID: 18410254
DOI: 10.1111/j.1537-2995.2008.01662.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Inactivation of parvovirus B19 during STIM-4 vapor heat treatment of three coagulation factor concentrates.PMID 18410254Read ↗

Parvovirus B19 transmission by heat‐treated clotting factor concentratesSemantic proximity Read ↗

Variability of parvovirus B19 genotype 2 in plasma products with different compositions in the inactivation sensitivity by liquid-heating.Semantic proximity Read ↗

Inactivation and neutralization of parvovirus B19 Genotype 3.Semantic proximity Read ↗

Neutralization of human parvovirus B19 by plasma and intravenous immunoglobulins.Semantic proximity Read ↗

Contamination of coagulation factor concentrates with human parvovirus B19 genotype 1 and 2.Semantic proximity Read ↗

Human parvovirus PARV4 in clotting factor VIII concentratesSemantic proximity Read ↗

Parvovirus B19 DNA in Factor VIII concentrates: effects of manufacturing procedures and B19 screening by nucleic acid testingSemantic proximity Read ↗

Parvovirus B19 transmission by a high‐purity factor VIII concentrateSemantic proximity Read ↗

Inactivation of HCV and HIV by microwave: a novel approach for prevention of virus transmission among people who inject drugs.Semantic proximity Read ↗

Prevalence of nucleic acid sequences specific for human parvoviruses, hepatitis A and hepatitis E viruses in coagulation factor concentratesSemantic proximity Read ↗

Frequency of contamination of coagulation factor concentrates with novel human parvovirus PARV4.Semantic proximity Read ↗

Extent of hepatitis E virus elimination is affected by stabilizers present in plasma products and pore size of nanofilters.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.